ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

Publication Year: 2023

Application Year: 2022

Priority Year: 2021

Jurisdictions: CA

Status: Pending

Inventors:

IOAN ANDREEA IOAN ANDREEA IOAN ANDREEA IOAN ANDREEA IOAN ANDREEA IOAN ANDREEA SAHIN UGUR SAHIN UGUR SAHIN UGUR SAHIN UGUR SAHIN UGUR SAHIN UGUR GIESEKE FRIEDERIKE GIESEKE FRIEDERIKE GIESEKE FRIEDERIKKE GIESEKE FRIEDERIKKE GIESEKE FRIEDERIKKE GIESEKE FRIEDERIKKE MUIK ALEXANDER MUIK ALEXANDER MUIK ALEXANDER MUIK ALEXANDER MUIK ALEXANDER MUIK ALEXANDER SCHODEL KRISTINA SCHODEL KRISTINA SCHODEL KRISTINA SCHÖDEL KRISTINA SCHÖDEL KRISTINA SCHÖDEL KRISTINA BEURSKENS FRANK BEURSKENS FRANK BEURSKENS FRANK BEURSKENS FRANK BEURSKENS FRANK BEURSKENS FRANK DE JONG ROB DE JONG ROB DE JONG ROB DE JONG ROB DE JONG ROB N DE JONG ROB N SCHUURMAN JANINE SCHUURMAN JANINE SCHUURMAN JANINE SCHUURMAN JANINE SCHUURMAN JANINE SCHUURMAN JANINE BREIJ ESTHER BREIJ ESTHER C W BREIJ ESTHER C W BREIJ ESTHER C W BREIJ ESTHER C W BREIJ ESTHER C W ALTINTAS ISIL ALTINTAS ISIL ALTINTAS ISIL ALTINTAS ISIL ALTINTAS ISIL ALTINTAS ISIL DE GOEJE PAULINE L DE GOEJE PAULINE L DE GOEJE PAULINE LINDA DE GOEJE PAULINE LINDA DE GOEJE PAULINE LINDA DE GOEJE PAULINE LINDA SATIJN DAVID SATIJN DAVID SATIJN DAVID SATIJN DAVID SATIJN DAVID SATIJN DAVID BOROSS PETER BOROSS PETER BORROS PETER BORROS PETER BORROS PETER BORROS PETER

Applicants:

Genmab (Denmark)

[NORA names:

Genmab

Private Research

Abstract

The present invention relates to antibodies capable of binding to human CD27 and to variants thereof comprising a modified Fc region comprising one or more mutations that enhances the Fc-Fc interaction of the antibody. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

Genmab (Denmark), Genmab AS IOAN ANDREEA, SAHIN UGUR, GIESEKE FRIEDERIKKE, (...more)

2023, CA-3231003-A1

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

Inventors:

Applicants:

Abstract

Patent Family Records (7)

ANTIBODIES CAPABLE OF BINDING CD27, VARIANTS AND USES THEREOF

Antibodies capable of binding CD27, variants thereof and uses thereof

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

Data Provider: Digital Science

LINKS
+

External Systems

SUBJECTS
+

DK Main Research Area

OECD Classification

AU/NZ FOR Classification

PATENT CATEGORIES
+

IPCR Classification

CPC Classification

METRICS
+

Citation Metrics

Inventors:

Applicants:

Abstract

Patent Family Records (7)

ANTIBODIES CAPABLE OF BINDING CD27, VARIANTS AND USES THEREOF

Antibodies capable of binding CD27, variants thereof and uses thereof

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

Data Provider: Digital Science

LINKS+

External Systems

SUBJECTS+

DK Main Research Area

OECD Classification

AU/NZ FOR Classification

PATENT CATEGORIES+

IPCR Classification

CPC Classification

METRICS+

Citation Metrics

Matching Records in NORA

DK Open Access Indicator

DK Green Classification

LINKS
+

SUBJECTS
+

PATENT CATEGORIES
+

METRICS
+